Nature Communications (Jul 2021)

Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers

  • Chandima Jeewandara,
  • Achala Kamaladasa,
  • Pradeep Darshana Pushpakumara,
  • Deshni Jayathilaka,
  • Inoka Sepali Aberathna,
  • Danasekara Rallage Saubhagya Rasikangani Danasekara,
  • Dinuka Guruge,
  • Thushali Ranasinghe,
  • Shashika Dayarathna,
  • Thilagaraj Pathmanathan,
  • Gayasha Somathilake,
  • Panambara Arachchige Deshan Madhusanka,
  • Shyrar Tanussiya Ramu,
  • Tibutius Thanesh Pramanayagam Jayadas,
  • Heshan Kuruppu,
  • Ayesha Wijesinghe,
  • Herath Mudiyanselage Thashmi Nimasha,
  • Dushantha Milroy,
  • Achini Anuja Nandasena,
  • Poththawela Kankanam Gamage Nilanka Sanjeewani,
  • Ruwan Wijayamuni,
  • Sudath Samaraweera,
  • Lisa Schimanski,
  • T. K. Tan,
  • Tao Dong,
  • Graham S. Ogg,
  • Alain Townsend,
  • Gathsaurie Neelika Malavige

DOI
https://doi.org/10.1038/s41467-021-24579-7
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 9

Abstract

Read online

Here the authors show in a large cohort of healthcare workers that one dose of the AZD1222 vaccine seroconverts 92.9% of vaccinees, irrespective of age and gender, and results in high antibody titers to wild-type SARS-CoV-2 but only low titers to the B.1.351 variant.